160 related articles for article (PubMed ID: 27860071)
1. Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics.
Qvit N; Kornfeld OS; Mochly-Rosen D
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15672-15679. PubMed ID: 27860071
[TBL] [Abstract][Full Text] [Related]
2. Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo.
Qvit N; Disatnik MH; Sho E; Mochly-Rosen D
J Am Chem Soc; 2016 Jun; 138(24):7626-35. PubMed ID: 27218445
[TBL] [Abstract][Full Text] [Related]
3. Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death.
Qvit N; Joshi AU; Cunningham AD; Ferreira JC; Mochly-Rosen D
J Biol Chem; 2016 Jun; 291(26):13608-21. PubMed ID: 27129213
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase C delta following cerebral ischemia leads to release of cytochrome C from the mitochondria via bad pathway.
Dave KR; Bhattacharya SK; Saul I; DeFazio RA; Dezfulian C; Lin HW; Raval AP; Perez-Pinzon MA
PLoS One; 2011; 6(7):e22057. PubMed ID: 21789211
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury.
Budas GR; Churchill EN; Mochly-Rosen D
Pharmacol Res; 2007 Jun; 55(6):523-36. PubMed ID: 17576073
[TBL] [Abstract][Full Text] [Related]
6. Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage.
Ikeno F; Inagaki K; Rezaee M; Mochly-Rosen D
Cardiovasc Res; 2007 Mar; 73(4):699-709. PubMed ID: 17234167
[TBL] [Abstract][Full Text] [Related]
7. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart.
Qi X; Vallentin A; Churchill E; Mochly-Rosen D
J Mol Cell Cardiol; 2007 Oct; 43(4):420-8. PubMed ID: 17825316
[TBL] [Abstract][Full Text] [Related]
8. Limb remote postconditioning alleviates cerebral reperfusion injury through reactive oxygen species-mediated inhibition of delta protein kinase C in rats.
Wang Q; Zhang X; Ding Q; Hu B; Xie Y; Li X; Yang Q; Xiong L
Anesth Analg; 2011 Nov; 113(5):1180-7. PubMed ID: 21865497
[TBL] [Abstract][Full Text] [Related]
9. A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.
Qvit N; Lin AJ; Elezaby A; Ostberg NP; Campos JC; Ferreira JCB; Mochly-Rosen D
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337069
[TBL] [Abstract][Full Text] [Related]
10. Activating deltaPKC antagonizes the protective effect of ERK1/2 inhibition against stroke in rats.
Castañeda D; Zhao H; Mochly-Rosen D; Steinberg GK
Brain Res; 2009 Jan; 1251():256-61. PubMed ID: 19063870
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function.
Kheifets V; Bright R; Inagaki K; Schechtman D; Mochly-Rosen D
J Biol Chem; 2006 Aug; 281(32):23218-26. PubMed ID: 16785226
[TBL] [Abstract][Full Text] [Related]
12. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.
Chen L; Hahn H; Wu G; Chen CH; Liron T; Schechtman D; Cavallaro G; Banci L; Guo Y; Bolli R; Dorn GW; Mochly-Rosen D
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11114-9. PubMed ID: 11553773
[TBL] [Abstract][Full Text] [Related]
13. Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase.
Siwko S; Mochly-Rosen D
Int J Biochem Cell Biol; 2007; 39(5):978-87. PubMed ID: 17337233
[TBL] [Abstract][Full Text] [Related]
14. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation.
Churchill EN; Murriel CL; Chen CH; Mochly-Rosen D; Szweda LI
Circ Res; 2005 Jul; 97(1):78-85. PubMed ID: 15961716
[TBL] [Abstract][Full Text] [Related]
15. Activation of protein kinase C delta by ψδRACK peptide promotes embryonic stem cell proliferation through ERK 1/2.
Garavello NM; Pena DA; Bonatto JM; Duarte ML; Costa-Junior HM; Schumacher RI; Forti FL; Schechtman D
J Proteomics; 2013 Dec; 94():497-512. PubMed ID: 24332066
[TBL] [Abstract][Full Text] [Related]
16. deltaPKC inhibition or varepsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification.
Monti M; Donnini S; Giachetti A; Mochly-Rosen D; Ziche M
J Mol Cell Cardiol; 2010 Apr; 48(4):746-56. PubMed ID: 19913548
[TBL] [Abstract][Full Text] [Related]
17. Translocation of deltaPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function.
Churchill EN; Szweda LI
Arch Biochem Biophys; 2005 Jul; 439(2):194-9. PubMed ID: 15963450
[TBL] [Abstract][Full Text] [Related]
18. Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia.
Shimohata T; Zhao H; Sung JH; Sun G; Mochly-Rosen D; Steinberg GK
J Cereb Blood Flow Metab; 2007 Aug; 27(8):1463-75. PubMed ID: 17293847
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C delta mediates cerebral reperfusion injury in vivo.
Bright R; Raval AP; Dembner JM; Pérez-Pinzón MA; Steinberg GK; Yenari MA; Mochly-Rosen D
J Neurosci; 2004 Aug; 24(31):6880-8. PubMed ID: 15295022
[TBL] [Abstract][Full Text] [Related]
20. Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC).
Kilpatrick LE; Standage SW; Li H; Raj NR; Korchak HM; Wolfson MR; Deutschman CS
J Leukoc Biol; 2011 Jan; 89(1):3-10. PubMed ID: 20724665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
